These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8839860)

  • 1. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
    Lapidot T; Grunberger T; Vormoor J; Estrov Z; Kollet O; Bunin N; Zaizov R; Williams DE; Freedman MH
    Blood; 1996 Oct; 88(7):2655-64. PubMed ID: 8839860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties.
    Freedman MH; Hitzler JK; Bunin N; Grunberger T; Squire J
    Stem Cells; 1996 Nov; 14(6):690-701. PubMed ID: 8948026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
    Pflumio F; Izac B; Katz A; Shultz LD; Vainchenker W; Coulombel L
    Blood; 1996 Nov; 88(10):3731-40. PubMed ID: 8916937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
    Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
    Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.
    Sirard C; Lapidot T; Vormoor J; Cashman JD; Doedens M; Murdoch B; Jamal N; Messner H; Addey L; Minden M; Laraya P; Keating A; Eaves A; Lansdorp PM; Eaves CJ; Dick JE
    Blood; 1996 Feb; 87(4):1539-48. PubMed ID: 8608245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
    Eisterer W; Jiang X; Christ O; Glimm H; Lee KH; Pang E; Lambie K; Shaw G; Holyoake TL; Petzer AL; Auewarakul C; Barnett MJ; Eaves CJ; Eaves AC
    Leukemia; 2005 Mar; 19(3):435-41. PubMed ID: 15674418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells.
    Verstegen MM; van Hennik PB; Terpstra W; van den Bos C; Wielenga JJ; van Rooijen N; Ploemacher RE; Wagemaker G; Wognum AW
    Blood; 1998 Mar; 91(6):1966-76. PubMed ID: 9490679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin enhances the production of myeloid cells, but not megakaryocytes, in juvenile chronic myelogenous leukemia.
    Sawai N; Koike K; Higuchi T; Ogami K; Oda M
    Blood; 1998 Jun; 91(11):4065-73. PubMed ID: 9596651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.
    Wang JC; Lapidot T; Cashman JD; Doedens M; Addy L; Sutherland DR; Nayar R; Laraya P; Minden M; Keating A; Eaves AC; Eaves CJ; Dick JE
    Blood; 1998 Apr; 91(7):2406-14. PubMed ID: 9516140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia.
    Cobaleda C; Gutiérrez-Cianca N; Pérez-Losada J; Flores T; García-Sanz R; González M; Sánchez-García I
    Blood; 2000 Feb; 95(3):1007-13. PubMed ID: 10648416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
    Lapidot T; Sirard C; Vormoor J; Murdoch B; Hoang T; Caceres-Cortes J; Minden M; Paterson B; Caligiuri MA; Dick JE
    Nature; 1994 Feb; 367(6464):645-8. PubMed ID: 7509044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft.
    Fraser CC; Kaneshima H; Hansteen G; Kilpatrick M; Hoffman R; Chen BP
    Blood; 1995 Sep; 86(5):1680-93. PubMed ID: 7655000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
    Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
    Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation.
    Zecca M; Rosti V; Pinto L; Comoli P; Carrà AM; Prete L; Bonetti F; Pedrazzoli P; Locatelli F; Cazzola M
    Med Pediatr Oncol; 1995 Mar; 24(3):166-70. PubMed ID: 7838038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice.
    Cashman JD; Lapidot T; Wang JC; Doedens M; Shultz LD; Lansdorp P; Dick JE; Eaves CJ
    Blood; 1997 Jun; 89(12):4307-16. PubMed ID: 9192753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell separation improves the sensitivity of detecting rare human normal and leukemic hematopoietic cells in vivo in NOD/SCID mice.
    Holyoake TL; Horrocks C; Thomas T; Eaves CJ; Eaves AC
    Cytotherapy; 2000; 2(6):411-21. PubMed ID: 12044221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice.
    Pilarski LM; Hipperson G; Seeberger K; Pruski E; Coupland RW; Belch AR
    Blood; 2000 Feb; 95(3):1056-65. PubMed ID: 10648422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.